Skip to content
10-K

Annual Report

ANIXA BIOSCIENCES, INC. ANIX

0001493152-26-001845

← back to feed
Filed
Jan 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jan 12, 2026 33.38M sh
Shares Diluted FY 2025 · Oct 31, 2025 32.45K sh
Shares Diluted FY 2025 · Oct 31, 2024 31.9K sh
Operating Cash Flow FY 2025 · Oct 31, 2025 −$7.17M
Operating Cash Flow FY 2025 · Oct 31, 2024 −$7.34M
Short Term Investments FY 2025 · Oct 31, 2025 $13.93M
Short Term Investments FY 2025 · Oct 31, 2024 $18.65M
Cash And Equivalents FY 2025 · Oct 31, 2025 $1.24M
Cash And Equivalents FY 2025 · Oct 31, 2024 $1.27M
Stockholders Equity FY 2025 · Oct 31, 2025 $15.16M
Stockholders Equity FY 2025 · Oct 31, 2024 $20M
Current Liabilities FY 2025 · Oct 31, 2025 $1.97M
Current Liabilities FY 2025 · Oct 31, 2024 $2.5M
Total Liabilities FY 2025 · Oct 31, 2025 $2.13M
Total Liabilities FY 2025 · Oct 31, 2024 $2.7M
Current Assets FY 2025 · Oct 31, 2025 $15.89M
Current Assets FY 2025 · Oct 31, 2024 $21.36M
Total Assets FY 2025 · Oct 31, 2025 $16.08M
Total Assets FY 2025 · Oct 31, 2024 $21.59M
Eps Diluted FY 2025 · Oct 31, 2025 −$0.34
Eps Diluted FY 2025 · Oct 31, 2024 −$0.39
Eps Basic FY 2025 · Oct 31, 2025 −$0.34
Eps Basic FY 2025 · Oct 31, 2024 −$0.39
Rd Expense FY 2025 · Oct 31, 2025 $5.07M
Rd Expense FY 2025 · Oct 31, 2024 $6.4M
Net Income FY 2025 · Oct 31, 2025 −$10.93M
Net Income FY 2025 · Oct 31, 2024 −$12.55M
Operating Income FY 2025 · Oct 31, 2025 −$11.7M
Operating Income FY 2025 · Oct 31, 2024 −$13.83M